首页> 外文OA文献 >Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy

【2h】

Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy

机译：在先前以奥沙利铂为基础的治疗进展的转移性结直肠癌患者中，阿柏西普联合FOLFIRI的安全性和疗效的时程

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ruff Paul; Ferry David R.; Lakomỳ Radek; Prausová Jana; Van Hazel Guy A.; Hoff Paulo M.; Cunningham David; Arnold Dirk; Schmoll Hans J.; Moiseyenko Vladimir M.; McKendrick Joseph J.; ten Tije Albert J.; Vishwanath Raghu L.; Bhargava Pankaj; Chevalier Soazig; Macarulla Teresa; Van Cutsem Eric;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [J] . Ruff Paul, Ferry David R., Lakomy Radek, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2015,第1a24期

机译：在先前以奥沙利铂为基础的治疗进展的转移性结直肠癌患者中，阿柏西普联合FOLFIRI的安全性和有效性的时程
2. Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy [J] . Ruff Paul, Ferry David R., Lakomy Radek, European journal of cancer: official journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR) . 2015,第1a24期

机译：在以前的欧洲依氯蛋白的治疗患者中与转移结直肠癌患者的患者的安全性和疗效的时间课程
3. The Clinical and Cost Effectiveness of Aflibercept in Combination with Irinotecan and Fluorouracil-Based Therapy (FOLFIRI) for the Treatment of Metastatic Colorectal Cancer Which has Progressed Following Prior Oxaliplatin-Based Chemotherapy: a Critique of the Evidence [J] . Wade Ros, Duarte Ana, Simmonds Mark, PharmacoEconomics . 2015,第5期

机译：Aflibercept联合伊立替康和氟尿嘧啶为基础的疗法（FOLFIRI）治疗转移性结直肠癌的临床和成本效益：先前基于奥沙利铂的化学疗法已取得进展：证据的批评
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. New Models of Colorectal Cancer to Facilitate Therapy Development for Metastatic Disease [D] . O'Rourke, Kevin. 2017

机译：新型结肠直肠癌促进转移性疾病治疗的疗效
6. Safety and Efficacy of Combined Yttrium 90 Resin Radioembolization with Aflibercept and FOLFIRI in a Patient with Metastatic Colorectal Cancer [O] . Andre De Souza, Kevin Pelham Daly, James Yoo, 2015

机译：钇90树脂放射栓塞联合阿柏西普和FOLFIRI在转移性结直肠癌患者中的安全性和有效性
7. Efficacy and safety of FOLFIRI/Aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after the failure of an oxaliplatin-based regimen [O] . N. Martínez-Lago, M. Carmona Campos, P. Gonzalez Villarroel, 2019

机译：在基于奥沙利替素的方案失败之后，在转移性结肠直肠癌（MCRC）之后的老年人人口中Fefiri / AfliBercept（FA）的疗效和安全性

Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy

著录项

相似文献

相关主题

期刊订阅